Supreme Court to Hear Cisco Appeal on Alien Tort Statute and Human Rights Liability 
Samsung Forecasts Strong Q4 Profit on AI-Driven Memory Chip Boom 
UBS Upgrades L’Oréal to Buy, Sees Strong Sales Momentum and 20% Upside 
FCC Exempts Select Foreign-Made Drones From U.S. Import Ban Until 2026 
Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move 
Ford Targets Level 3 Autonomous Driving by 2028 with New EV Platform and AI Innovations 
Rio Tinto–Glencore Merger Talks Spark Investor Debate Over Value, Strategy and Coal Exposure 
Aktis Oncology Prices Upsized IPO at $18, Raising $318 Million in Major Biotech Debut 
xAI Cash Burn Highlights the High Cost of Competing in Generative AI 
BlueScope Steel Shares Slip After Board Rejects A$13.2 Billion Takeover Bid 
Chevron Sees Path to Boost Venezuela Oil Output by 50% After Trump Administration Talks 
Hanwha Ocean Shares Rise on Plans to Expand U.S. Shipbuilding Capacity 
Boeing 737 MAX 10 Advances in FAA Testing as Certification Delays Continue 
Stellantis to End Plug-In Hybrid Sales in the U.S. as Demand Shifts Toward Traditional Hybrids 
Johnson & Johnson Secures Tariff Exemption by Agreeing to Lower Drug Prices in the U.S. 
Vitol to Ship First U.S. Naphtha Cargo to Venezuela Under New Oil Supply Deal 
BETHLEHEM, Pa., Oct. 25, 2017 -- B. Braun Medical Inc., a market leader in regional anesthesia, has epidural and spinal anesthesia products with NRFit™ connectors available for sale in compliance with International Organization for Standardization (ISO) 80369-6 and California State Legislation.
ISO standards for small bore connectors are intended to help prevent misconnections and improve patient safety. In accordance with ISO standards, all healthcare facilities are expected to transition to products that meet this standard for neuraxial and regional anesthesia. Additionally, California took legislative action to mandate that healthcare facilities transition to non-luer epidural products at the start of this year.
The current design of universal luer connectors poses the risk of inadvertent misconnections. The new NRFit connector design helps to avoid connections between medical devices meant for neuraxial administration and devices used for IV, enteral and other applications. By using devices with NRFit connectors, clinicians can help reduce the risk of misconnection between applications and help reduce medical errors.
“B. Braun has been at the forefront of preparing for this change,” said Peter McGregor, Director of Marketing, Pain Control at B. Braun. “We have taken an active role in helping our customers comply with the evolving industry safety standards, including transitioning to products with NRFit connectors. As a leader in regional anesthesia products and a strong advocate for patient safety, B. Braun is committed to providing the safest delivery of medications in healthcare settings to help improve patient outcomes.”
For more information, visit www.BBraunNRFit.com.
About B. Braun
B. Braun Medical Inc., a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. B. Braun Medical is headquartered in Bethlehem, Pa., and is part of the B. Braun Group of Companies in the U.S., which includes B. Braun Interventional Systems, Aesculap® and CAPS®.
Globally, the B. Braun Group of Companies employs more than 58,000 employees in 64 countries. Guided by its Sharing Expertise® philosophy, B. Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs. To learn more about B. Braun Medical, visit www.BBraunUSA.com.
Contact:
Jason Ford
B. Braun Medical Inc.
610.997.4722
[email protected]
